Skip to main content
  • Dilating Drops and Medical Decision-Making

    Does documenting that the patient was counseled regarding the risks and possible side effects of dilating drops count toward the prescription counseling requirement of medical decision-making (MDM)?

    It does not unless the physician is prescribing atropine for amblyopia treatment. The keyword is prescribing; it involves issuing the prescription to the patient for use outside the office.